Showing 1 - 20 results of 904 for search '(((( ai marked decrease ) OR ( b marked decrease ))) OR ( a latent decrease ))', query time: 0.47s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies. by Philip P. Mshelbwala (11278898)

    Published 2025
    “…<p>Posterior distribution of the effect of the latent variable on the probability of seeking traditional remedies after a potential dog bite indicates a decreased likelihood of individuals seeking traditional remedies.…”
  7. 7
  8. 8

    Raw data of the charts in Fig 5. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  9. 9

    Antibodies used in western blot analysis. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  10. 10

    Raw data of the charts in Fig 3. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  11. 11

    Raw data of the charts in Fig 1. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  12. 12

    Raw data of the charts in Fig 6. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  13. 13

    Raw data of the charts in Fig 2. by Kam Pui Tam (19746865)

    Published 2024
    “…Concurrently, venetoclax inhibited Bcl-2 upregulated by either LMP-1 or EBNA-3C. Bort/venetoclax decreased the expression of phosphorylated p65 and Bcl-2 at serine 70 thereby suppressing the NF-κB signaling pathway and promoting apoptosis, respectively. …”
  14. 14
  15. 15
  16. 16

    <b>Effect of Marked Weight Loss on Adipose Tissue Biology in People with Obesity and Type 2 Diabetes</b> by Dmitri Samovski (305400)

    Published 2025
    “…</p><p dir="ltr"><b>Results: </b>Weight loss: <a href="" target="_blank">i) </a><a href="" target="_blank">decreased adipose tissue </a>expression of genes related to extracellular matrix remodeling; ii) decreased adipose tissue expression of SERPINE 1 which encodes plasminogen activator inhibitor-1 (PAI-1); iii) did not decrease adipose tissue immune cell content or expression of genes involved in inflammation; iv) decreased adipose tissue ceramide content; v) decreased plasma <a href="" target="_blank">PAI-1 </a>and leptin concentrations and increased plasma high-molecular weight (HMW) adiponectin; and vi) decreased plasma small extracellular vesicle (sEV) concentration and the sEV content of microRNAs proposed to inhibit insulin action, and completely reversed the inhibitory effect of plasma sEVs on insulin signaling in myotubes.…”
  17. 17
  18. 18
  19. 19
  20. 20

    Flow chart of data screening and analysis. by Yan She (8639796)

    Published 2025
    “…In contrast, the BMD, BV/TV, and Tb.N in the 12-week model group exhibited a modest but non-significant decrease relative to the 9-week model group. The concentration level of BALP and TRACP-5b did not differ significantly between the 6-week model group and the sham operation group. …”